PMGC (NASDAQ:ELAB – Get Free Report) and Star Equity (NASDAQ:STRR – Get Free Report) are both small-cap multi-sector conglomerates companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation.
Profitability
This table compares PMGC and Star Equity’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| PMGC | N/A | -80.35% | -61.56% |
| Star Equity | -3.44% | -1.17% | -0.73% |
Insider and Institutional Ownership
22.2% of PMGC shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 0.1% of PMGC shares are owned by company insiders. Comparatively, 33.5% of Star Equity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| PMGC | $590,084.00 | 5.25 | -$6.25 million | ($400.97) | -0.01 |
| Star Equity | $172.16 million | 0.21 | -$5.92 million | ($2.05) | -4.76 |
Star Equity has higher revenue and earnings than PMGC. Star Equity is trading at a lower price-to-earnings ratio than PMGC, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for PMGC and Star Equity, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| PMGC | 1 | 0 | 0 | 0 | 1.00 |
| Star Equity | 1 | 2 | 1 | 1 | 2.40 |
Star Equity has a consensus price target of $16.50, suggesting a potential upside of 69.23%. Given Star Equity’s stronger consensus rating and higher possible upside, analysts plainly believe Star Equity is more favorable than PMGC.
Risk and Volatility
PMGC has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Comparatively, Star Equity has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500.
Summary
Star Equity beats PMGC on 10 of the 15 factors compared between the two stocks.
About PMGC
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
About Star Equity
Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
